CTLT Quote, Trading Chart, Catalent Inc.

$116.40 Last:

2.37% Change Percent:

$114.78 Open:

$116.40 Previous Close:

$117.8 High:

$114 Low:

838,443 Volume:

03/01/2021 04:56:19 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2021-03-01	114.78	116.4	117.8	114	838,443
2021-02-26	112.94	113.71	114.55	111.48	983,563
2021-02-25	114.53	112.25	115.07	111.2	1,468,289
2021-02-24	112.61	115.15	115.54	112.26	945,533
2021-02-23	113.93	112.8	114	109.34	1,324,160
2021-02-22	117.42	114.32	117.645	114.26	845,662
2021-02-19	118.99	117.99	119.51	117.88	726,762
2021-02-18	120.74	118.24	120.74	117.12	728,219
2021-02-17	122	120.95	122.49	119.31	575,335
2021-02-16	125.29	122.78	127.68	122.3	1,108,680
2021-02-15	122.41	125.27	125.6345	122.14	744,999
2021-02-12	122.41	125.27	125.6345	122.14	744,993
2021-02-11	119.94	123	124.87	119.45	1,445,229
2021-02-10	115.17	119.22	119.92	115.09	1,148,146
2021-02-09	113.34	114.17	116.17	113.34	914,344
2021-02-08	114.14	113.5	114.7	112.58	606,564
2021-02-05	113.62	113.53	114.41	111.93	878,109
2021-02-04	113.55	113.43	114.17	112.69	725,895
2021-02-03	118.9	113.83	119.05	112.54	1,077,044
2021-02-02	122.2	117.73	124.48	117.73	1,504,309

Stock Information

Catalent Inc. Company Name:

CTLT Stock Symbol:

NYSE Market:

Get CTLT Alerts

News, Short Squeeze, Breakout and More Instantly...

CTLT - Catalent, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that members of its executive leadership team will virtually ...
CTLT - Moderna Hits a Short-Term Vaccine Manufacturing Delay, Still on Track for First 100 Million Doses by End of March

Moderna (NASDAQ: MRNA) has hit a bit of a snag with the manufacturing of its COVID-19 vaccine. The company's fill-and-finish contractor, Catalent (NYSE: CTLT) , is experiencing delays with some of the doses it's responsible for getting out the door. The companies didn't disc...
CTLT - Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029

Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that its wholly owned subsidiary, ...